AstraZeneca’s breast cancer pill fails in a late-stage trial

Shares dip as analysts call the trial outcome a ‘manageable setback’ for investors

Black News Black News
Sep 12, 2026 - 07:17
AstraZeneca’s breast cancer pill fails in a late-stage trial
Shares dip as analysts call the trial outcome a ‘manageable setback’ for investors
All The News 24/7